Literature DB >> 366792

Movement of calcium ions and their role in the activation of platelets.

P Massini, R Käser-Glanzmann, E F Lüscher.   

Abstract

The increase of the cytoplasmic Ca-concentration plays a central role in the initiation of platelet activation. Four kinds of movements of Ca-ions are presumed to occur during this process: a) Ca-ions liberated from membranes induce the rapid shape change. b) Vesicular organelles release Ca-ions into the cytoplasm which initiate the release reaction. c) The storage organelles called dense bodies, secrete their contents including Ca-ions to the outside during the release reaction. d) At the same time a rearrangement of the plasma membrane occurs, resulting in an increase in its permeability for Ca-ions as well as in an increase in the number of Ca-binding sites. Since most processes occurring during platelet activation are reversible, the platelet must be equipped with a mechanism which removes Ca-ions from the cytoplasm. A vesicular fraction obtained from homogenized platelets indeed accumulates Ca actively. This Ca-pump is stimulated by cyclic AMP and protein kinase; it may be involved in the recovery of platelets after activation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 366792

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

1.  Biochemical mechanisms in 5-hydroxytryptamine-induced human platelet aggregation.

Authors:  F de Clerck; B Xhonneux; R van de Wiele
Journal:  Agents Actions       Date:  1985-12

2.  Aggregation, membrane potential, and transport in platelets of spontaneously hypertensive rats.

Authors:  G M Kravtsov; S N Orlov; Y V Postnov
Journal:  Pflugers Arch       Date:  1984-11       Impact factor: 3.657

3.  Studies of platelets with heavy metal impregnation techniques.

Authors:  R Yarom; R More; Y Havivi; G Lijovetzky; S Meyer
Journal:  Histochem J       Date:  1982-01

Review 4.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

5.  Relationship between structure of phenothiazine analogues and their activity on platelet calcium fluxes.

Authors:  J Enouf; S Lévy-Toledano
Journal:  Br J Pharmacol       Date:  1984-03       Impact factor: 8.739

Review 6.  Nitric oxide-releasing/generating polymers for the development of implantable chemical sensors with enhanced biocompatibility.

Authors:  Yiduo Wu; Mark E Meyerhoff
Journal:  Talanta       Date:  2007-06-28       Impact factor: 6.057

7.  Inhibition of human platelet functions by cyclandelate.

Authors:  W E van den Hoven; D W Hall
Journal:  Drugs       Date:  1987       Impact factor: 9.546

8.  Involvement of bivalent cations and arachidonic acid in neutrophil aggregation.

Authors:  J T O'Flaherty
Journal:  Inflammation       Date:  1980-06       Impact factor: 4.092

9.  Multifunctional Hemostatic PVA/Chitosan Sponges Loaded with Hydroxyapatite and Ciprofloxacin.

Authors:  Saif El-Din Al-Mofty; Ali H Karaly; Wessam Awad Sarhan; Hassan M E Azzazy
Journal:  ACS Omega       Date:  2022-04-11

10.  Effect of Blood Component Coatings of Enosseal Implants on Proliferation and Synthetic Activity of Human Osteoblasts and Cytokine Production of Peripheral Blood Mononuclear Cells.

Authors:  Lucie Himmlova; Dana Kubies; Hana Hulejova; Jirina Bartova; Tomas Riedel; Jana Stikarova; Jiri Suttnar; Vlasta Pesakova
Journal:  Mediators Inflamm       Date:  2016-08-29       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.